Robert Deegan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Deegan has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Margaret Wood
6 shared publications- Mias Pretorius
Department of Anesthesiology, Vanderbilt University Medical School, Nashville, TN
6 shared publications Alastair J. J. Wood
From the Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn
5 shared publicationsHuai Bing He
4 shared publicationsC. Michael Stein
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA
3 shared publicationsAlastair J J Wood
Vanderbilt University School of Medicine Division of Clinical Pharmacology
2 shared publications
Latest Publications
- 1 January 2019
- Published by Elsevier in Heart Rhythm
- Vol. 16 (1) , 12-17
Feasibility of left atrial appendage device closure following chronically failed surgical ligation
- 1 January 2019
- Published by Elsevier in Heart Rhythm
- Vol. 16 (1) , 12-17
Feasibility of left atrial appendage device closure following chronically failed surgical ligation
- Open Access
Incidental Finding of a Double Interatrial Septum in a Patient Undergoing Atrial Fibrillation Ablation
- Open Access
- 26 June 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-11
The Risk of Oxygen during Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial
Anesthesiologists administer excess supplemental oxygen (hyper-oxygenation) to patients during surgery to avoid hypoxia. Hyper-oxygenation, however, may increase the generation of reactive oxygen species and cause oxidative damage. In cardiac surgery, increased oxidative damage has been associated with postoperative kidney and brain injury. We hypothesize that maintenance of normoxia during cardiac surgery (physiologic oxygenation) decreases kidney injury and oxidative damage compared to hyper-oxygenation. The Risk of Oxygen during Cardiac Surgery (ROCS) trial will randomly assign 200 cardiac surgery patients to receive physiologic oxygenation, defined as the lowest fraction of inspired oxygen (FIO2) necessary to maintain an arterial hemoglobin saturation of 95 to 97%, or hyper-oxygenation (FIO2 = 1.0) during surgery. The primary clinical endpoint is serum creatinine change from baseline to postoperative day 2, and the primary mechanism endpoint is change in plasma concentrations of F2-isoprostanes and isofurans. Secondary endpoints include superoxide production, clinical delirium, myocardial injury, and length of stay. An endothelial function substudy will examine the effects of oxygen treatment and oxidative stress on endothelial function, measured using flow mediated dilation, peripheral arterial tonometry, and wire tension myography of epicardial fat arterioles. The ROCS trial will test the hypothesis that intraoperative physiologic oxygenation decreases oxidative damage and organ injury compared to hyper-oxygenation in patients undergoing cardiac surgery. ClinicalTrials.gov, ID: NCT02361944 . Registered on the 30th of January 2015.
- 26 June 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-11
Open AccessThe Risk of Oxygen during Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial
Anesthesiologists administer excess supplemental oxygen (hyper-oxygenation) to patients during surgery to avoid hypoxia. Hyper-oxygenation, however, may increase the generation of reactive oxygen species and cause oxidative damage. In cardiac surgery, increased oxidative damage has been associated with postoperative kidney and brain injury. We hypothesize that maintenance of normoxia during cardiac surgery (physiologic oxygenation) decreases kidney injury and oxidative damage compared to hyper-oxygenation. The Risk of Oxygen during Cardiac Surgery (ROCS) trial will randomly assign 200 cardiac surgery patients to receive physiologic oxygenation, defined as the lowest fraction of inspired oxygen (FIO2) necessary to maintain an arterial hemoglobin saturation of 95 to 97%, or hyper-oxygenation (FIO2 = 1.0) during surgery. The primary clinical endpoint is serum creatinine change from baseline to postoperative day 2, and the primary mechanism endpoint is change in plasma concentrations of F2-isoprostanes and isofurans. Secondary endpoints include superoxide production, clinical delirium, myocardial injury, and length of stay. An endothelial function substudy will examine the effects of oxygen treatment and oxidative stress on endothelial function, measured using flow mediated dilation, peripheral arterial tonometry, and wire tension myography of epicardial fat arterioles. The ROCS trial will test the hypothesis that intraoperative physiologic oxygenation decreases oxidative damage and organ injury compared to hyper-oxygenation in patients undergoing cardiac surgery. ClinicalTrials.gov, ID: NCT02361944 . Registered on the 30th of January 2015.
- 1 September 2016
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 62 (5) , 539-544
Outcomes of Patients Implanted Using a Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump
As ventricular-assist devices (VADs) are increasingly employed in heart failure management, a leading cause of mortality, new literature is consistently published on less-invasive implantation techniques. Although early perioperative outcomes have been shown to be favorable with minimally invasive left thoracotomy (LT) approaches compared with conventional sternotomy (CS), studies comparing long-term outcomes are lacking. We set out to evaluate long-term follow up between LT and CS approach. In a single center, retrospective review, data on patients with similar demographic profiles were collected. HeartWare (HVAD) implantation was performed by either CS or LT. Analysis was performed on perioperative adverse outcomes, and 6 month postoperative adverse events. Primary objectives of the study included comparative outcomes of morbidity and mortality between both groups at 180 days postimplantation. Eighty-one (n = 81) bridge to transplant (BTT) patients underwent CS or LT HVAD implantation. Perioperative transfusion (p = 0.04) favored the LT cohort compared with CS, with a median of 6 units and 8 units transfused for each group, respectively. No survival difference was observed between both groups at 6 months postimplantation (p = 0.52). Clinical outcomes at an average of 6 month follow up showed no difference in adverse events, including common postoperative VAD complications such as infection and right heart failure. Miniaturization of LVAD size and improvement in technology has allowed expansion of interest in alternative surgical approaches for HVAD implantation. For BTT patients, no difference in early outcome was observed 6 months after implantation using a left LT versus CS technique.
- 1 September 2016
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 62 (5) , 539-544
Outcomes of Patients Implanted Using a Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump
As ventricular-assist devices (VADs) are increasingly employed in heart failure management, a leading cause of mortality, new literature is consistently published on less-invasive implantation techniques. Although early perioperative outcomes have been shown to be favorable with minimally invasive left thoracotomy (LT) approaches compared with conventional sternotomy (CS), studies comparing long-term outcomes are lacking. We set out to evaluate long-term follow up between LT and CS approach. In a single center, retrospective review, data on patients with similar demographic profiles were collected. HeartWare (HVAD) implantation was performed by either CS or LT. Analysis was performed on perioperative adverse outcomes, and 6 month postoperative adverse events. Primary objectives of the study included comparative outcomes of morbidity and mortality between both groups at 180 days postimplantation. Eighty-one (n = 81) bridge to transplant (BTT) patients underwent CS or LT HVAD implantation. Perioperative transfusion (p = 0.04) favored the LT cohort compared with CS, with a median of 6 units and 8 units transfused for each group, respectively. No survival difference was observed between both groups at 6 months postimplantation (p = 0.52). Clinical outcomes at an average of 6 month follow up showed no difference in adverse events, including common postoperative VAD complications such as infection and right heart failure. Miniaturization of LVAD size and improvement in technology has allowed expansion of interest in alternative surgical approaches for HVAD implantation. For BTT patients, no difference in early outcome was observed 6 months after implantation using a left LT versus CS technique.
- 1 January 2016
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 122 (1) , 34-36
Failed Percutaneous Transcatheter Tricuspid Valve-in-Valve Replacement Caused by Retained Valve Holder
- 1 January 2016
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 122 (1) , 34-36
Failed Percutaneous Transcatheter Tricuspid Valve-in-Valve Replacement Caused by Retained Valve Holder
- 22 July 2015
- Published by Wiley in Transfusion
- Vol. 55 (11) , 2752-2758
Reducing intraoperative red blood cell unit wastage in a large academic medical center
BACKGROUND The wastage of red blood cell (RBC) units within the operative setting results in significant direct costs to health care organizations. Previous education‐based efforts to reduce wastage were unsuccessful at our institution. We hypothesized that a quality and process improvement approach would result in sustained reductions in intraoperative RBC wastage in a large academic medical center. STUDY DESIGN AND METHODS Utilizing a failure mode and effects analysis supplemented with time and temperature data, key drivers of perioperative RBC wastage were identified and targeted for process improvement. RESULTS Multiple contributing factors, including improper storage and transport and lack of accurate, locally relevant RBC wastage event data were identified as significant contributors to ongoing intraoperative RBC unit wastage. Testing and implementation of improvements to the process of transport and storage of RBC units occurred in liver transplant and adult cardiac surgical areas due to their history of disproportionately high RBC wastage rates. Process interventions targeting local drivers of RBC wastage resulted in a significant reduction in RBC wastage (p < 0.0001; adjusted odds ratio, 0.24; 95% confidence interval, 0.15‐0.39), despite an increase in operative case volume over the period of the study. Studied process interventions were then introduced incrementally in the remainder of the perioperative areas. CONCLUSIONS These results show that a multidisciplinary team focused on the process of blood product ordering, transport, and storage was able to significantly reduce operative RBC wastage and its associated costs using quality and process improvement methods.
- 22 July 2015
- Published by Wiley in Transfusion
- Vol. 55 (11) , 2752-2758
Reducing intraoperative red blood cell unit wastage in a large academic medical center
BACKGROUND The wastage of red blood cell (RBC) units within the operative setting results in significant direct costs to health care organizations. Previous education‐based efforts to reduce wastage were unsuccessful at our institution. We hypothesized that a quality and process improvement approach would result in sustained reductions in intraoperative RBC wastage in a large academic medical center. STUDY DESIGN AND METHODS Utilizing a failure mode and effects analysis supplemented with time and temperature data, key drivers of perioperative RBC wastage were identified and targeted for process improvement. RESULTS Multiple contributing factors, including improper storage and transport and lack of accurate, locally relevant RBC wastage event data were identified as significant contributors to ongoing intraoperative RBC unit wastage. Testing and implementation of improvements to the process of transport and storage of RBC units occurred in liver transplant and adult cardiac surgical areas due to their history of disproportionately high RBC wastage rates. Process interventions targeting local drivers of RBC wastage resulted in a significant reduction in RBC wastage (p < 0.0001; adjusted odds ratio, 0.24; 95% confidence interval, 0.15‐0.39), despite an increase in operative case volume over the period of the study. Studied process interventions were then introduced incrementally in the remainder of the perioperative areas. CONCLUSIONS These results show that a multidisciplinary team focused on the process of blood product ordering, transport, and storage was able to significantly reduce operative RBC wastage and its associated costs using quality and process improvement methods.
- 1 January 2015
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 34 (1) , 107-112
In-hospital outcomes of a minimally invasive off-pump left thoracotomy approach using a centrifugal continuous-flow left ventricular assist device
- 1 January 2015
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 34 (1) , 107-112
In-hospital outcomes of a minimally invasive off-pump left thoracotomy approach using a centrifugal continuous-flow left ventricular assist device
- 1 August 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (4) , 629-632
Takotsubo Cardiomyopathy and Coronary Vasospasm During Orthotopic Liver Transplantation: Separate Entities or Common Mechanism?
- 1 August 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (4) , 629-632
Takotsubo Cardiomyopathy and Coronary Vasospasm During Orthotopic Liver Transplantation: Separate Entities or Common Mechanism?
- 1 August 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (4) , 568-573
Extending the Use of the Pacing Pulmonary Artery Catheter for Safe Minimally Invasive Cardiac Surgery
- 1 August 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (4) , 568-573
Extending the Use of the Pacing Pulmonary Artery Catheter for Safe Minimally Invasive Cardiac Surgery
- 1 December 2006
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 103 (6) , 1412-1413
Placement of the TandemHeart® Percutaneous Left Ventricular Assist Device
- 1 December 2006
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 103 (6) , 1412-1413
Placement of the TandemHeart® Percutaneous Left Ventricular Assist Device